https://www.prnewswire.com/news-releases/intarcia-ceo-to-present-company-progress-interim-phase-3-data-and-key-milestones-at-jp-morgan-239907191.html
/PRNewswire/ -- Intarcia Therapeutics, Inc. today announced that Chairman, President and CEO Kurt Graves will present a Company overview today at the J.P....
present companyintarciaceoprogressinterim
https://www.prnewswire.com/news-releases/intarcia-therapeutics-appoints-dr-eddie-li-vice-president-and-global-head-of-regulatory-affairs-215817811.html
/PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the hiring of Dr. Eddie Li to the newly created position of Vice President and Global Head of...
intarcia therapeuticseddie livice presidentappointsdr
https://www.prnewswire.com/news-releases/intarcia-enrolls-first-patients-in-freedom-global-phase-3-program-for-itca-650-in-type-2-diabetes-199345561.html
/PRNewswire/ -- Intarcia Therapeutics, Inc. announced today the enrollment of the first patients in FREEDOM-1, the first of four planned Phase 3 clinical...
intarciafirstpatientsfreedomglobal